Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study.

Buti, Sebastiano; Donini, Maddalena; Bersanelli, Melissa; Gattara, Alessia; Leonardi, Francesco; Passalacqua, Rodolfo

Buti, Sebastiano; Donini, Maddalena; Bersanelli, Melissa; Gattara, Alessia; Leonardi, Francesco; Passalacqua, Rodolfo.

Afiliação

Buti S; Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.
Donini M; Oncology Unit, Oncology Department, ASST Ospedale di Cremona, Cremona, Italy.
Bersanelli M; Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy. bersamel@libero.it.
Gattara A; Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.
Leonardi F; Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.
Passalacqua R; Oncology Unit, Oncology Department, ASST Ospedale di Cremona, Cremona, Italy.

Drugs R D ; 18(2): 163, 2018 06.

Article em En | MEDLINE | ID: mdl-29808389

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: Drugs R D Assunto da revista: TERAPIA POR MEDICAMENTOS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google